365 related articles for article (PubMed ID: 27374998)
1. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
[TBL] [Abstract][Full Text] [Related]
2. Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals.
Jokanovic N; Tan EC; Dooley MJ; Kirkpatrick CM; Elliott RA; Bell JS
J Eval Clin Pract; 2016 Oct; 22(5):677-82. PubMed ID: 26804719
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents.
Kummer I; Reissigová J; Lukačišinová A; Ortner Hadžiabdić M; Stuhec M; Liperoti R; Finne-Soveri H; Onder G; van Hout H; Fialová D
Ann Med; 2024 Dec; 56(1):2357232. PubMed ID: 38833339
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
[TBL] [Abstract][Full Text] [Related]
5. Clinical consequences of polypharmacy in elderly.
Maher RL; Hanlon J; Hajjar ER
Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
[TBL] [Abstract][Full Text] [Related]
6. Improving medication appropriateness in nursing home residents by enhancing interprofessional cooperation: A study protocol.
Schaffler-Schaden D; Pitzer S; Schreier M; Dellinger J; Brandauer-Stickler B; Lainer M; Flamm M; Osterbrink J
J Interprof Care; 2018 Jul; 32(4):517-520. PubMed ID: 29521554
[TBL] [Abstract][Full Text] [Related]
7. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic prescribing practice in residential aged care facilities--health care providers' perspectives.
Lim CJ; Kwong MW; Stuart RL; Buising KL; Friedman ND; Bennett NJ; Cheng AC; Peleg AY; Marshall C; Kong DC
Med J Aust; 2014 Jul; 201(2):98-102. PubMed ID: 25045989
[TBL] [Abstract][Full Text] [Related]
9. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.
Turner JP; Edwards S; Stanners M; Shakib S; Bell JS
BMJ Open; 2016 Mar; 6(3):e009781. PubMed ID: 26966056
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the implementation of quality use of medicines in residential aged care.
Cheek J; Gilbert A; Ballantyne A; Penhall R
Drugs Aging; 2004; 21(12):813-24. PubMed ID: 15382960
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
14. Residential medication management reviews in Australian residential aged care facilities.
Sluggett JK; Bell JS; Lang C; Corlis M; Whitehead C; Wesselingh SL; Inacio MC
Med J Aust; 2021 May; 214(9):432-433. PubMed ID: 33410175
[No Abstract] [Full Text] [Related]
15. Process, impact and outcomes of medication review in Australian residential aged care facilities: A systematic review.
Chen EYH; Wang KN; Sluggett JK; Ilomäki J; Hilmer SN; Corlis M; Bell JS
Australas J Ageing; 2019 Sep; 38 Suppl 2():9-25. PubMed ID: 31496065
[TBL] [Abstract][Full Text] [Related]
16. The DE-PHARM Project: A Pharmacist-Driven Deprescribing Initiative in a Nursing Facility.
Pruskowski J; Handler SM
Consult Pharm; 2017 Aug; 32(8):468-478. PubMed ID: 29029668
[TBL] [Abstract][Full Text] [Related]
17. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
18. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
19. Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.
Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Mendez-Valera P
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):425-37. PubMed ID: 25703585
[TBL] [Abstract][Full Text] [Related]
20. Is my older cancer patient on too many medications?
Turner JP; Shakib S; Bell JS
J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
